Skills in genetics and clinical research are in demand as academia and industry try to tailor treatments to their patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Reprinted from Nature 410, 393–394 (2001).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Smaglik, P. Pharmacogenetics initiative galvanizes public and private sectors. Nat Biotechnol 19, 691–692 (2001). https://doi.org/10.1038/90324
Issue Date:
DOI: https://doi.org/10.1038/90324